Revisiting Foam Sclerotherapy: Challenging the 7 mm Dogma
Haroun Gajraj, a Self-Employed Phlebologist, posted on LinkedIn.
”An excellent demonstration of the utility of Foam Sclerotherapy for Superficial Venous Disease.
Dogma (aka Guidelines) tells us that Foam is only useful for veins up to 7 mm.
Even then, long-term durability is widely thought to be inferior to endothermal ablation.
Thank you Massimo Pozza for sharing your expertise.
Those who get inferior results are not doing it right. Simple as that!”
Quoting Massimo Pozza‘s post:
” This is a very interesting case because the patient had a VGS dilation of about 2.4 cm at 30 cm from the crosse (average diameter calculated on the teaching of Dr. Sica of Paris) with this abnormal antero-medial collateral.
I treated the VGS with direct puncture to the middle lower III of the thigh with 1% R L/A 1/4 foam about 8cc and then I treated the coarse collateral with atxscl 0.5/0.7% foam at the control after about 6 years the patient does not have recanalization of either the VGS or the coarse collateral and I limited myself to the treatment of some small collateral legs.
This is to highlight the
The fact is that very often it is enough to use delicate concentrations to have excellent results and that I prefer to use more aggressive concentrations depending on the patient’s response, which is different from person to person.
I always use Nadiax 3 nanoemulsion cream before and after the treatment and in this case elastocontension 35 mmHg for 7 days.”
” 
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?